Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Humana Inc. before investing.

In this article, we go over a few key elements for understanding Humana Inc.’s stock price such as:

• Humana Inc.’s current stock price and volume
• Why Humana Inc.’s stock price changed recently
• Upgrades and downgrades for HUM from analysts
• HUM’s stock price momentum as measured by its relative strength

About Humana Inc. (HUM)

Before we jump into Humana Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Want to learn more about Humana Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Humana Inc..

Humana Inc.’s Stock Price as of Market Close

As of May 13, 2026, 9:47 AM, CST, Humana Inc.’s stock price was $296.840.

Humana Inc. is up 0.5% from its previous closing price of $295.350.

During the last market session, Humana Inc.’s stock traded between $292.070 and $300.890. Currently, there are approximately 120.33 million shares outstanding for Humana Inc..

Humana Inc.’s price-earnings (P/E) ratio is currently at 31.6, which is high compared to the Health Care Providers & Services industry median of 22.8. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Humana Inc. Stock Price History

Humana Inc.’s (HUM) price is currently up 25.55% so far this month.

During the month of May, Humana Inc.’s stock price has reached a high of $300.890 and a low of $231.120.

Over the last year, Humana Inc. has hit prices as high as $315.348 and as low as $163.110. Year to date, Humana Inc.’s stock is up 15.89%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Humana Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 12, 2026, there were 0 analysts who downgraded Humana Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Humana Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Humana Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Humana Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Humana Inc. (HUM) by visiting AAII Stock Evaluator.

Relative Price Strength of Humana Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 12, 2026, Humana Inc. has a weighted four-quarter relative price strength of 13.70%, which translates to a Momentum Score of 85 and is considered to be Very Strong.

Want to learn more about how Humana Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Humana Inc. Stock Price: Bottom Line

As of May 13, 2026, Humana Inc.’s stock price is $296.840, which is up 0.5% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Humana Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.